Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.02.19
Views: 2823

Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas Mottet

Professor Karim Fizazi chairs a discussion with Professors Eleni Efstathiou, Nicholas Mottet, and Boris Hadaschek on the latest data presented at ASCO GU 2019 in San Francisco, specifically focused on patients with non-metastatic CRPC.

The group highlights the clinical landscape and treatment recommendations for these patients, and discuss how new data presented at ASCO GU, such the ARAMIS and SPARTAN studies, may impact treatment regimens and guidelines for this patient population.

Topics including the requirements and cost value of next generation PET imaging technology are also discussed, as well as the recommended preventative measures to manage bone health.

Guidelines for the treatment of CRPC
Results from the PROSPER and SPARTAN clinical trials
Clinical profile of darolutamide in the ARAMIS trial
Next generation imaging in patients with CRPC
Personalisation of drugs to increase quality of life
Bone health in CRPC patients
New treatment recommendations for patients with CRPC

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).

Related videos

follow us

CML Life Banner

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation